Quebec, Quebec, Canada CTI Capital is the famous VC, which was founded in 2006. The main office of represented VC is situated in the Quebec. The fund was located in North America if to be more exact in Canada.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the CTI Capital, startups are often financed by Fonds de solidaritu00e9 FTQ, Desjardins Venture Capital, CTI Life Sciences Fund. The meaningful sponsors for the fund in investment in the same round are Vertex Management, Toshiba Corporation, The Carlyle Group. In the next rounds fund is usually obtained by Domain Associates, CTI Life Sciences Fund, Advanced Biotechnologies Venture Fund.
Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2009. Opposing the other organizations, this CTI Capital works on 4 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Among the most popular portfolio startups of the fund, we may highlight Enobia Pharma, BeXcom, Xagenic. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are E-Commerce, Logistics. For fund there is a match between the location of its establishment and the land of its numerous investments - Canada. The fund has exact preference in a number of founders of portfolio startups.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 8 Tian Zai Xian | - |
| aucfan Co.,Ltd. | Chiyoda, Japan |
| Bronze Valley | Alabama, Birmingham, United States |
| Calliode | France, Ile-de-France, Paris |
| CF Capital | China, Guangdong, Guangzhou |
| Commercial Growth Fund | - |
| Energy Queensland | - |
| ESO Capital Group | England, London, United Kingdom |
| GSM | - |
| Harvest Capital Management | Beijing, Beijing, China |
| Kaplan Ventures | Florida, Miami, United States |
| Kintetsu Venture Partners | Japan, Osaka, Osaka Prefecture |
| Logan Capital AG | Sankt Gallen, Sankt Gallen, Switzerland |
| Metrocall | Alexandria, United States, Virginia |
| Nova Founders Capital | England, London, United Kingdom |
| Shenzhen Zowee Technology | China, Guangdong, Tianjin |
| Variant | - |
| Washington Post | District of Columbia, United States, Washington |
| Xigu Wei Dianzi | China, Shaanxi, Xian Shi |
| Zencap | Berlin, Berlin, Germany |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Xagenic | $25M | 14 Jul 2014 | Old Toronto, Ontario, Canada | ||
Xagenic | $10M | 30 Jan 2012 | Canada, Ontario | ||
Enobia Pharma | $50M | 10 Aug 2009 | Montreal, Quebec |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Xagenic | $25M | 14 Jul 2014 | Old Toronto, Ontario, Canada | ||
Xagenic | $10M | 30 Jan 2012 | Canada, Ontario | ||
Enobia Pharma | $50M | 10 Aug 2009 | Montreal, Quebec |
